≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

Use of glatiramer acetate

Endpoint Browser

MSMED_GLATIRAMERACETATE

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Medicine purchases: ATC — L03AX13

1 out of 7 registries used, show all original rules.

637

4. Check minimum number of events

Min. number of events 3
637

5. Include endpoints

None

637

6. Filter based on genotype QC (FinnGen only)

637

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze
DF2

Case counts by codes

↥

FinnGen case counts by registry codes:

Not enough data for upset plot.

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 637 528 109
Unadjusted period prevalence (%) 0.16 0.18 0.05
Median age at first event (years) 38.26 37.72 40.88

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
564
Matched controls
5639
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
109
Kela drug reimbursment
Multiple sclerosis
9850.4
323.0
545
23
157
Kela drug reimbursment
Dimethyl fumarate, glatiramer acetate, interferon beta and teriflunomid (Multiple sclerosis)
2601.0
323.0
501
17
L03AX13
ATC
glatiramer acetate; parenteral
+∞
323.0
564
*
303
Kela drug reimbursment
Dimethyl fumarate, interferon beta, glatiramer acetate and teriflunomid (Multiple sclerosis)
9780.6
323.0
541
19
G35
ICD-10 Finland
Multiple sclerosis
+∞
323.0
564
42
L03AB07
ATC
interferon beta-1a; parenteral
517.4
311.7
284
11
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
31.9
231.9
331
240
N86
ICPC
Multiple sclerosis
296.0
215.2
207
11
H46
ICD-10 Finland
Optic neuritis
163.4
191.9
194
18
164
Kela drug reimbursment
Fingolimod
349.3
177.8
171
7
L03AB08
ATC
interferon beta-1b; parenteral
729.4
169.7
159
*
L04AA27
ATC
fingolimod; oral
630.6
151.2
143
*
G37.9
ICD-10 Finland
Demyelinating disease of central nervous system, unspecified
134.1
150.2
156
16
353
Kela drug reimbursment
Cladribine and fingolimod
318.2
146.8
143
6
N04BB01
ATC
amantadine; oral
72.8
144.0
162
31
L04AA31
ATC
teriflunomide; oral
289.1
135.5
133
6
L04AX07
ATC
dimethyl fumarate; oral
216.8
133.0
133
8
N07XX09
ATC
[U] dimethyl fumarate; oral
443.4
112.7
109
*
M03BX01
ATC
baclofen; systemic
42.1
98.6
123
37
TAB00
NOMESCO Finland
Lumbar puncture
18.7
98.3
158
115
Z01.0
ICD-10 Finland
Examination of eyes and vision
7.9
85.4
230
451
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
31.2
78.3
105
41
XKD00
NOMESCO Finland
Uroflowmetry
13.1
74.1
138
136
G04BD09
ATC
trospium; oral
43.1
73.5
91
25
XCK00
NOMESCO Finland
Perimetry
12.5
69.9
133
136
N06BA07
ATC
modafinil; oral
139.4
69.7
73
6
XA800
NOMESCO Finland
Neuropsychological investigation
14.8
69.4
121
102
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
43.3
68.7
85
23
2AB04
NOMESCO Finland
NA
196.0
67.7
69
*
XKD06
NOMESCO Finland
Physiologic investigation of micturition
29.9
67.3
91
36
G04BD12
ATC
mirabegron; oral
11.7
64.4
126
135
ZX120
NOMESCO Finland
Intravenous
8.4
63.5
154
242
F02.89*G35
ICD-10 Finland
Dementia in multiple sclerosis
556.8
52.4
51
*
H02AB04
ATC
methylprednisolone; systemic
5.4
50.3
176
438
N03AE01
ATC
clonazepam; systemic
9.7
48.1
103
127
G04BD04
ATC
oxybutynin; oral, transdermal
13.7
47.3
84
71
R20.2
ICD-10 Finland
Paraesthesia of skin
7.2
45.9
120
203
XKC03
NOMESCO Finland
Water cystometry
16.9
45.7
74
50
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
22.5
45.2
66
33
UKC02
NOMESCO Finland
Cystoscopy
6.7
45.2
126
233
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
9.1
45.0
100
131
G36.9
ICD-10 Finland
Acute disseminated demyelination, unspecified
127.9
44.5
47
*
G04BD07
ATC
tolterodine; oral
15.0
43.6
74
56
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
13.8
43.6
77
64
4AA23
NOMESCO Finland
NA
+∞
42.2
40
*
R1250
NOMESCO Finland
Evaluation of functional capability
19.8
40.7
62
35
N03AX12
ATC
gabapentin; oral
4.7
40.4
159
436
G04BD08
ATC
solifenacin; oral
9.7
39.7
84
100
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
5.5
37.2
121
267
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
7.3
36.0
91
144
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
5.6
35.7
114
245
TKC22
NOMESCO Finland
Catheterisation instruction
23.2
34.1
49
23
N31.8
ICD-10 Finland
Other neuromuscular dysfunction of bladder
120.4
32.0
34
*
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
10.3
30.8
62
67
3400A
ICD-9 Finland
Multiple sclerosis[SCLEROSIS MULTIPLEX (DISSEMINATA)]
+∞
30.5
29
*
SPAT1229
SPAT
Assessment of need for aid
7.3
30.3
76
118
N31.9
ICD-10 Finland
Neuromuscular dysfunction of bladder, unspecified
26.8
29.2
40
16
XCW99
NOMESCO Finland
Other investigative procedure of eye
5.1
29.1
99
226
H53.2
ICD-10 Finland
Diplopia
11.8
28.4
53
49
NA2CG
NOMESCO Finland
Thoracal spine extensive MRI examination with high intensity magnet
40.1
27.4
34
9
N03AX16
ATC
pregabalin; oral
3.1
27.4
184
757
G97.0
ICD-10 Finland
Cerebrospinal fluid leak from spinal puncture
9.7
26.1
54
61
R35
ICD-10 Finland
Polyuria
7.2
26.0
65
100
H48.1*G35
ICD-10 Finland
Retrobulbar neuritis in multiple sclerosis
272.4
25.9
26
*
O99.3
ICD-10 Finland
Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium
8.1
25.6
59
80
N05CF01
ATC
zopiclone; oral
2.8
25.6
215
1014
G04BD11
ATC
fesoterodine; oral
13.7
24.3
42
33
G95.8
ICD-10 Finland
Other specified diseases of spinal cord
90.7
23.9
26
*
R33
ICD-10 Finland
Retention of urine
8.3
23.1
52
68
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.7
22.0
182
836
KCV12
NOMESCO Finland
Urinary bladder endoscopic botulin therapy
19.4
22.0
33
18
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
16.6
20.8
33
21
A06AD11
ATC
lactulose; oral
4.0
20.7
88
248
TAB22
NOMESCO Finland
Stoppin epidural fluid escape with coagulated blood
8.3
20.5
46
60
J01EA01
ATC
trimethoprim; systemic
2.5
20.4
198
989
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
4.8
20.0
70
163
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
4.6
19.8
72
174
L03AB13
ATC
peginterferon beta-1a; parenteral
76.3
19.8
22
*
C10AC01
ATC
colestyramine; oral
8.6
19.3
42
52
N31.1
ICD-10 Finland
Reflex neuropathic bladder, not elsewhere classified
47.8
19.3
23
5
TKC20
NOMESCO Finland
Catheterisation of bladder
6.0
19.1
54
98
G04CA02
ATC
tamsulosin; oral
5.0
18.1
60
132
G36.0
ICD-10 Finland
Neuromyelitis optica [Devic]
+∞
17.8
17
*
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
3.1
17.8
111
419
XKD03
NOMESCO Finland
Urethral pressure profilometry
10.6
17.6
34
34
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
5.0
17.5
58
127
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
8.5
17.0
37
46
N30.0
ICD-10 Finland
Acute cystitis
3.0
16.8
110
427
N29
ICPC
Neurological sympt/complt other
13.2
16.8
29
23
R4110
NOMESCO Finland
Physiotherapy
2.4
16.4
163
808
N31.2
ICD-10 Finland
Flaccid neuropathic bladder, not elsewhere classified
31.1
16.2
21
7
R4120
NOMESCO Finland
Occupational therapy
4.2
15.7
62
162
N06AX16
ATC
venlafaxine; oral
2.6
15.6
132
598
N39.4
ICD-10 Finland
Other specified urinary incontinence
4.5
15.6
56
134
XCD10
NOMESCO Finland
Electrophysiological examination of eye
8.2
15.3
34
44
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
4.4
15.2
56
137
RF120
NOMESCO Finland
NA
12.3
15.2
27
23
R4150
NOMESCO Finland
Neuropsychological rehabilitation
14.5
15.1
25
18
A28
ICPC
Limited function/disability NOS
4.1
15.1
60
158
SPAT1231
SPAT
Assessment of adjustments needed in living environment
15.6
15.0
24
16
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
15.9
14.5
23
15
SPAT1215
SPAT
Assessment of need for medical rehabilitation
4.9
14.4
48
106
N32.83
ICD-10 Finland
Nozzle synergy in the bladder neck
23.0
14.3
20
9
H55
ICD-10 Finland
Nystagmus and other irregular eye movements
54.8
13.9
16
*
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
7.9
13.8
31
41
N03AF01
ATC
carbamazepine; oral, rectal
4.5
13.5
48
114
H53.1
ICD-10 Finland
Subjective visual disturbances
3.8
13.5
59
170
L28
ICPC
Limited function/disability (L)
3.0
13.3
80
292
A02BC02
ATC
pantoprazole; systemic
2.0
13.1
360
2671
L04AA40
ATC
cladribine; oral
51.2
12.9
15
*
N06AB04
ATC
citalopram; systemic
2.2
12.9
151
798
N31.0
ICD-10 Finland
Uninhibited neuropathic bladder, not elsewhere classified
71.5
12.6
14
*
L04AX01
ATC
azathioprine; systemic
4.2
12.6
48
122
H51.2
ICD-10 Finland
Internuclear ophthalmoplegia
132.8
12.5
13
*
N28
ICPC
Limited function/disability (N)
12.8
12.2
21
17
SPAT1216
SPAT
Assessment of functional ability
3.1
12.2
70
248
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
13.8
12.0
20
15
TPH04
NOMESCO Finland
Cathetrisation of vein
2.4
11.9
117
565
G04CA01
ATC
alfuzosin; oral
5.0
11.9
38
81
H02AB07
ATC
prednisone; oral
2.6
11.8
94
405
NA7BG
NOMESCO Finland
Spine and spinal cord MRI examination with high intensity magnet
16.8
11.7
18
11
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.6
11.6
90
383
N04BD01
ATC
selegiline; oral
17.5
11.3
17
10
RF420
NOMESCO Finland
NA
8.8
11.1
23
27
N04BC05
ATC
pramipexole; oral
3.6
10.9
49
145
SPAT1262
SPAT
Handing over of treatment supplies
2.5
10.8
91
404
J01CA08
ATC
pivmecillinam; oral
1.8
10.8
288
2053
R42
ICD-10 Finland
Dizziness and giddiness
2.3
10.7
111
548
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
4.3
10.7
39
96
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.9
10.6
190
1177
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.0
10.5
146
821
34099
ICD-8 Finland
Multiple sclerosis
112.0
10.5
11
*
G04BD10
ATC
darifenacin; oral
112.0
10.5
11
*
N06AX21
ATC
duloxetine; oral
2.4
9.9
88
403
308
Kela drug reimbursment
Alprostadil, sildenafil and combination product containing aviptadil and phentolamine
26.5
9.8
13
5
N06AA09
ATC
amitriptyline; systemic
2.9
9.8
61
228
M03BX02
ATC
tizanidine; oral
1.8
9.7
396
3184
U07
ICPC
Urine symptom/complaint other
3.9
9.6
39
106
SPAT1325
SPAT
Vaccination
1.9
9.6
156
928
H49.2
ICD-10 Finland
Sixth [abducent] nerve palsy
15.4
9.6
15
10
R39.1
ICD-10 Finland
Other difficulties with micturition
6.4
9.5
24
39
3773B
ICD-9 Finland
Disorders of optic nerve and visual pathways, Optic neuritis[NEURITIS RETROBULBARIS]
101.7
9.4
10
*
R5110
SPAT
NA
8.9
9.4
19
22
N03AF02
ATC
oxcarbazepine; oral
5.0
9.3
29
61
N32.82
ICD-10 Finland
Instability of the detrusor vesicae muscle
11.7
9.1
16
14
6BA02
NOMESCO Finland
NA
37.3
9.0
11
*
RF410
NOMESCO Finland
NA
7.6
9.0
20
27
H47.2
ICD-10 Finland
Optic atrophy
24.5
8.9
12
5
H57.1
ICD-10 Finland
Ocular pain
4.0
8.9
34
88
G50.0
ICD-10 Finland
Trigeminal neuralgia
6.1
8.8
23
39
4AA36
NOMESCO Finland
NA
50.8
8.7
10
*
R03CA02
ATC
ephedrine; oral
50.8
8.7
10
*
A06AC01
ATC
ispaghula (psylla seeds); oral
2.0
8.5
123
695
359
Kela drug reimbursment
Mirabegroni
20.4
8.5
12
6
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.4
8.4
71
317
G37.3
ICD-10 Finland
Acute transverse myelitis in demyelinating disease of central nervous system
+∞
8.4
8
*
RF432
NOMESCO Finland
NA
+∞
8.4
8
*
WW400
NOMESCO Finland
Plasmaferesis
+∞
8.4
8
*
CS444
NOMESCO Finland
Visual field testing with Octopus automated perimetry
5.7
8.1
22
40
J01MA02
ATC
ciprofloxacin; systemic
1.7
7.9
189
1265
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.5
7.9
60
253
H52.1
ICD-10 Finland
Myopia
3.4
7.8
36
110
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.7
7.7
195
1323
G04BDXX
ATC
NA
45.6
7.7
9
*
J05AB01
ATC
aciclovir; systemic
1.8
7.7
141
868
R15
ICD-10 Finland
Faecal incontinence
6.6
7.5
18
28
Z50.1
ICD-10 Finland
Other physical therapy
3.2
7.5
37
120
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
3.2
7.5
37
120
RS221
NOMESCO Finland
NA
5.7
7.4
20
36
U04
ICPC
Incontinence urine
5.0
7.4
22
45
XCK10
NOMESCO Finland
Photography of fundus of eye
2.7
7.3
47
181
K59.0
ICD-10 Finland
Constipation
3.6
7.2
31
90
SPAT1167
SPAT
Insertion of urinary catheter
8.1
7.1
15
19
KA1AE
NOMESCO Finland
Kidney ultrasound examination
5.3
7.0
20
39
U13
ICPC
Bladder symptom/complaint other
4.4
7.0
24
57
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.8
6.9
121
730
G04BE03
ATC
sildenafil; oral
14.0
6.9
11
8
SAA02
NOMESCO Finland
Basic examination of mouth
1.6
6.9
392
3280
K59.00
ICD-10 Finland
Constipation caused by slow bowel passage (SCT)
6.8
6.9
16
24
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
6.8
6.9
16
24
CA1CG
NOMESCO Finland
Eye and orbita extensive MRI examination with high intensity magnet
11.1
6.8
12
11
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
3.7
6.8
28
79
TKC10
NOMESCO Finland
Percutaneous puncture of bladder
16.9
6.8
10
6
G82.2
ICD-10 Finland
Paraplegia, unspecified
22.8
6.7
9
*
H47.0
ICD-10 Finland
Disorders of optic nerve, not elsewhere classified
22.8
6.7
9
*
RS340
NOMESCO Finland
NA
22.8
6.7
9
*
N06AX11
ATC
mirtazapine; oral
1.7
6.7
179
1231
XF400
NOMESCO Finland
ECG with 12 standard connections
2.2
6.6
65
311
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.2
6.6
63
299
J05AB11
ATC
valaciclovir; oral
2.0
6.6
80
423
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.6
6.5
190
1332
C03CA01
ATC
furosemide; systemic
2.2
6.4
66
323
H48.1
ICD-10 Finland
Retrobulbar neuritis in diseases classified elsewhere
70.6
6.4
7
*
L01BB04
ATC
cladribine; systemic
70.6
6.4
7
*
N07AA03
ATC
distigmine; systemic
70.6
6.4
7
*
Z43.5
ICD-10 Finland
Attention to cystostomy
18.3
6.3
9
5
G37.8
ICD-10 Finland
Other specified demyelinating diseases of central nervous system
+∞
6.3
6
*
119
Kela drug reimbursment
Trigeminal neuralgia or glossofaryngeusneuralgia
27.0
6.2
8
*
R27.0
ICD-10 Finland
Ataxia, unspecified
27.0
6.2
8
*
N06CA01
ATC
amitriptyline and psycholeptics; systemic
2.2
6.1
59
280
J01XX05
ATC
methenamine; oral
12.7
6.1
10
8
U08
ICPC
Urinary retention
12.7
6.1
10
8
R51.80
ICD-10 Finland
Headache
1.8
6.0
102
606
K59.09
ICD-10 Finland
Constipation, unspecified
3.1
6.0
30
99
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
3.1
6.0
30
99

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
110
10
132.75
218.14
3.1
2.3
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
158
93
22.26
198.51
1.2
1.2
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
155
94
21.47
191.81
1.2
1.1
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
99
43
27.08
139.86
4.1
2.7
e9/l
1.1
1.2
0.40
49
24
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
87
33
30.38
128.77
2.5
2.3
%
14.4
10.8
1.00
41
16
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
83
34
27.92
119.41
4.5
2.6
e6/l
471.0
444.0
0.21
72
28
(3005719) IgG [Mass/volume] in Serum or Plasma
210
388
7.58
117.08
3.8
2.5
g/l
9.4
10.3
3.68
194
360
(42870588) Differential panel, method unspecified - Blood
432
1627
6.14
109.32
13.0
5.5
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
142
181
9.81
108.68
1.9
1.6
iu/ml
0.0
0.0
—
8
22
(3001604) Monocytes [#/volume] in Blood
539
2621
7.87
97.01
15.8
5.5
e9/l
0.5
0.5
0.94
520
2352
(3006315) Basophils [#/volume] in Blood
538
2632
7.72
95.50
15.9
5.5
e9/l
0.0
0.0
0.34
520
2358
(3028026) IgM [Mass/volume] in Serum or Plasma
166
301
7.11
92.68
3.7
1.7
g/l
1.0
1.2
2.77
160
282
(3022096) Basophils/100 leukocytes in Blood
505
2381
6.41
92.17
15.2
5.6
%
0.8
0.7
2.11
499
2241
(3019069) Monocytes/100 leukocytes in Blood
516
2485
6.67
91.60
15.2
5.8
%
9.2
7.9
19.19
511
2362
(3019198) Lymphocytes [#/volume] in Blood
540
2718
7.48
90.64
15.8
5.5
e9/l
1.6
2.0
11.90
525
2471
(3013115) Eosinophils [#/volume] in Blood
540
2741
7.37
89.04
16.0
5.9
e9/l
0.2
0.2
1.15
525
2479
(21494815) CD4 cells/100 lymphocytes in Specimen
73
44
18.61
88.81
3.0
2.1
%
49.2
46.2
—
29
5
(3006504) Eosinophils/100 leukocytes in Blood
510
2472
6.33
88.59
15.2
5.5
%
3.2
2.7
5.61
504
2328
(3002030) Lymphocytes/100 leukocytes in Blood
517
2579
6.33
85.39
15.1
5.5
%
25.6
29.5
14.96
511
2445
(3018010) Neutrophils/100 leukocytes in Blood
512
2555
6.12
83.88
14.8
5.3
%
59.6
56.8
7.31
507
2426
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
63
31
22.44
83.87
2.5
2.3
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
541
3012
6.28
72.33
16.1
8.4
e9/l
3.6
4.0
5.58
528
2675
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
62
42
16.25
70.82
5.0
2.4
e6/l
914.2
796.9
0.40
40
15
(21494814) CD8 cells/100 lymphocytes in Specimen
47
17
29.77
69.92
2.3
2.1
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
253
864
4.20
65.10
4.9
2.2
e6/l
4.3
8.4
3.51
228
761
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
49
26
20.33
62.85
1.2
1.2
miu/ml
1760.3
1764.3
0.01
49
26
(3002582) Erythrocytes [#/volume] in Urine
311
1267
3.84
61.29
6.5
2.5
e6/l
13.2
53.5
2.43
269
945
(3026008) Bacteria identified in Urine by Culture
307
1246
3.83
60.72
5.4
2.2
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
41
15
29.14
60.62
2.4
2.1
e6/l
34.2
221.0
—
19
10
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
41
15
29.14
60.62
6.3
3.1
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
289
1154
3.75
58.06
5.8
2.4
e6/l
0.1
0.4
2.34
242
843
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
68
76
9.90
56.45
1.2
1.1
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
536
3296
4.95
54.29
10.3
3.5
e6/l
72.5
480.0
0.50
11
33
(3026782) Osmolality of Urine
228
809
3.83
54.08
4.6
2.2
mosm/kgh2o
539.8
544.4
0.11
208
697
(36304419) Bacteria [Presence] in Urine
283
1165
3.57
53.35
5.9
2.4
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
408
2142
3.52
51.28
2.7
2.3
nmol/l
97.6
74.6
28.33
388
2005
(3018095) Leukocytes [#/volume] in Urine
338
1606
3.35
49.62
7.7
3.0
e6/l
61.2
93.8
0.39
280
1045
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
49
42
12.56
48.61
1.0
1.1
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
162
500
4.00
46.25
1.4
1.5
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
49
48
10.98
44.50
1.0
1.1
mg/l
222.3
227.1
0.07
35
40
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
50
51
10.55
44.15
1.1
1.1
mg/l
51.6
29.2
3.24
36
39
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
187
660
3.60
43.55
4.8
2.2
e6/l
0.9
1.0
0.19
115
345
(4027681)
45
44
10.93
40.87
1.2
1.2
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
529
3536
3.93
40.12
9.2
3.7
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
403
2317
3.01
39.27
14.4
7.6
e9/l
0.0
0.0
0.12
367
1929
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
171
611
3.46
38.59
5.1
2.2
e6/l
5.8
4.0
0.64
100
297
(3015736) pH of Urine
357
1987
2.81
35.84
5.6
2.8
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
419
2606
2.78
32.66
6.7
3.0
estimate
0.0
0.0
0.80
97
489
(3021601) Nitrite [Presence] in Urine by Test strip
415
2574
2.76
32.43
9.0
4.1
estimate
0.0
0.0
0.50
96
512
(3035350) Ketones [Presence] in Urine by Test strip
413
2573
2.72
31.68
6.8
2.9
estimate
0.0
0.0
0.00
94
500
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
63
131
5.23
29.19
1.1
1.5
mg/l
435.2
422.0
0.14
57
121
(3017143) Hepatitis C virus Ab [Presence] in Serum
185
815
2.79
27.99
1.5
1.6
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
33
37
9.35
27.04
3.1
2.5
%
48.8
48.5
—
19
9
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
32
8
42.05
26.06
1.1
1.0
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
379
2414
2.41
25.41
5.6
5.4
umol/l
9.4
9.6
0.34
361
2279
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
39
58
7.10
25.32
1.0
1.1
—
—
—
0
0
(40758558) Short blood count panel - Blood
239
1262
2.43
24.31
10.2
6.0
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
39
61
6.75
24.17
1.1
1.1
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
53
113
5.03
23.80
1.1
1.8
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
54
118
4.91
23.56
1.3
1.8
e6/l
641.2
172.9
0.50
44
97
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
54
118
4.91
23.56
1.1
1.7
e6/l
8.0
5.0
0.95
43
93
(3011397) Hemoglobin [Presence] in Urine by Test strip
214
1095
2.44
23.15
6.0
2.9
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
112
418
3.04
22.60
5.0
4.3
%
0.6
1.0
0.61
21
101
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
38
63
6.35
22.26
1.1
1.1
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
238
1303
2.32
21.83
1.7
1.7
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
50
110
4.85
21.62
4.1
4.1
e9/l
3.7
4.4
1.80
50
110
(3021440) Promyelocytes/100 leukocytes in Blood
106
393
3.04
21.59
5.2
4.4
%
0.0
0.1
2.65
18
90
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
31
43
7.53
21.37
1.0
1.1
u/l
0.9
1.1
—
8
23
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
50
112
4.76
21.16
4.2
4.5
%
61.3
58.1
1.11
50
112
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
113
443
2.89
20.78
2.5
2.0
u/l
5765.9
4250.7
0.14
35
183
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
53
127
4.46
20.64
1.4
1.2
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
102
381
3.00
20.46
4.9
4.3
%
0.2
0.8
2.08
13
70
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
18
13
14.22
19.42
2.2
2.2
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
99
376
2.93
19.22
5.4
4.5
%
0.0
0.1
0.71
14
75
(3018677) aPTT in Platelet poor plasma by Coagulation assay
129
564
2.61
19.11
2.3
2.0
s
29.4
29.5
0.10
122
551
(40760892) CBC W Ordered Manual Differential panel - Blood
231
1399
2.02
15.25
11.2
4.1
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
62
206
3.23
15.07
1.5
1.3
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
304
2036
1.94
14.90
7.5
2.9
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
44
119
3.90
14.58
1.1
1.4
mmol/l
3.7
3.6
0.15
38
111
(3007164) IgA [Mass/volume] in Serum or Plasma
201
1210
1.97
13.14
2.9
1.4
g/l
1.9
2.2
3.36
155
798
(3052851) Hemolysis interference index of Serum or Plasma
41
121
3.55
11.99
1.8
2.8
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
209
1312
1.88
11.84
8.5
3.2
estimate
0.0
0.0
1.08
95
508
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
15
5
30.66
11.69
1.1
1.2
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
237
1553
1.84
11.68
6.1
2.6
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
78
339
2.48
11.45
2.5
1.7
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
467
5356
0.52
11.16
3.4
3.6
mmol/l
1.5
1.5
0.24
428
5122
(46235355) HIV 1 and 2 tests - Meaningful Use set
240
1602
1.80
10.98
1.7
1.9
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
443
5153
0.54
10.86
3.1
3.3
mmol/l
1.3
1.3
1.19
412
4921
(3024561) Albumin [Mass/volume] in Serum or Plasma
262
1801
1.77
10.81
4.5
4.5
g/l
37.4
37.1
0.36
242
1694
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
477
5414
0.53
10.36
3.7
3.9
mmol/l
3.0
2.9
1.00
437
5165
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
464
3790
1.83
10.19
7.0
6.7
u/l
73.8
74.0
0.04
434
3593
(3019150) Specific gravity of Urine by Refractometry
174
1076
1.85
10.09
7.7
3.1
kg/l
1.0
1.0
0.43
27
144
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
473
5373
0.54
10.03
3.5
3.6
mmol/l
4.9
4.9
0.88
439
5161
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
12
13
9.39
9.90
1.1
1.0
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
161
2436
0.55
9.86
2.1
2.3
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
348
2650
1.69
9.51
4.6
4.2
mmol/l
6.1
6.4
2.85
328
2424
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
44
159
2.90
9.26
1.4
1.6
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
21
47
4.59
8.89
1.0
1.9
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
150
921
1.82
8.76
4.1
3.7
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
622
5765
4.35
8.65
18.0
8.5
u/l
27.7
26.1
1.76
613
5641
(3019550) Sodium [Moles/volume] in Serum or Plasma
584
5280
2.27
7.84
13.4
9.9
mmol/l
139.8
139.6
1.37
576
5157
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
20
48
4.27
7.78
1.2
1.6
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
585
5301
2.27
7.67
13.5
10.0
mmol/l
3.9
3.9
0.44
575
5164
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
256
1883
1.60
7.44
5.3
3.1
u/l
28.6
29.0
0.08
246
1800
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
593
5426
2.34
7.20
14.3
10.1
mg/l
18.8
18.6
0.05
469
4120
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
102
588
1.87
7.19
1.6
1.7
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
21
56
3.84
7.13
1.3
2.0
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
203
1433
1.61
6.89
4.2
5.4
inr
1.0
1.1
2.65
57
492
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
472
4051
1.64
6.79
5.0
2.9
u/l
49.9
39.1
1.52
456
3904
(3007566) Smooth muscle Ab [Titer] in Serum
38
151
2.61
6.73
1.4
1.2
titre
43.3
98.0
—
6
15
(21494755) Public health laboratory ask at order entry panel
49
954
0.47
6.12
1.1
1.3
—
—
—
0
0
(40761535) Cells panel - Urine sediment
61
311
2.06
6.12
8.0
3.2
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
71
384
1.96
6.05
1.6
1.6
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
80
457
1.86
5.78
8.2
3.0
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
52
259
2.10
5.56
1.9
1.3
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
71
397
1.89
5.49
1.6
1.6
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
69
387
1.88
5.28
2.3
2.3
e9/l
4.5
4.1
0.47
62
336
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
38
770
0.46
5.27
1.5
1.6
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
258
2016
1.47
5.18
6.8
5.9
mmol/l
1.2
1.2
0.27
218
1707
(3001019) Free T4 and TSH panel - Serum or Plasma
25
586
0.40
5.02
1.3
1.7
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
14
38
3.74
4.67
2.3
2.8
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
23
88
2.67
4.44
1.4
1.7
g/l
0.7
0.6
0.12
16
66
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
25
546
0.44
4.22
1.2
1.4
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
225
1771
1.42
4.13
6.7
5.3
mmol/l
1.2
1.2
0.22
204
1627
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
419
4660
0.71
4.07
4.0
4.2
mmol/mol
37.0
38.1
1.64
389
4456
(3021960) Folate [Moles/volume] in Serum or Plasma
123
863
1.53
4.07
1.5
1.4
nmol/l
22.4
21.2
0.35
107
772
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
84
539
1.64
4.06
2.4
2.5
umol/l
6.7
5.0
0.74
77
455
(3016650) Hepatitis A virus Ab [Presence] in Serum
24
99
2.48
4.01
1.0
1.1
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
13
38
3.47
3.92
1.1
1.1
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
13
38
3.47
3.92
2.4
1.8
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
13
38
3.47
3.92
1.1
1.1
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
165
1241
1.44
3.85
1.9
2.0
u/l
197.9
158.4
0.29
158
1183
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
102
698
1.55
3.77
2.6
2.8
ng/l
333.5
350.4
0.03
45
369
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
59
943
0.59
3.75
1.6
1.4
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
11
30
3.71
3.65
2.0
3.3
—
—
—
0
0
(3012544) pH of Venous blood
50
291
1.78
3.45
8.2
3.6
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
204
1621
1.38
3.43
1.9
1.8
pmol/l
99.1
98.0
0.11
101
900
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
21
88
2.43
3.42
1.0
1.1
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
541
5038
1.49
3.23
12.9
8.4
ml/min/173m2
96.7
91.8
8.70
470
4123
(3022621) pH of Urine by Test strip
50
299
1.73
3.16
4.5
2.1
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
34
180
1.94
3.16
2.7
2.0
iu/l
11.5
5.5
1.03
15
71
(3013512) EKG study
142
1078
1.41
3.10
3.1
2.8
—
—
—
0
0
(3018418) pH of Serum or Plasma
152
1168
1.40
3.09
4.8
3.5
ph
7.4
7.4
1.10
16
225
(3000330) Specific gravity of Urine by Test strip
34
182
1.92
3.07
5.7
2.3
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
12
40
3.04
2.98
1.1
1.1
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
76
1080
0.66
2.86
1.2
1.3
u/ml
1.7
11.6
4.41
26
472
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
28
148
1.93
2.65
11.6
2.5
%
0.6
0.7
0.62
28
143
(3002032) Base excess in Venous blood by calculation
46
285
1.66
2.59
8.6
3.4
mmol/l
1.9
1.8
0.15
41
231
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
12
44
2.76
2.56
1.5
1.2
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
6
11
5.50
2.55
1.2
1.4
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
46
291
1.63
2.41
8.6
3.4
kpa
5.8
5.8
0.06
46
284
(3000492) Spirometry study
38
603
0.61
2.36
1.2
1.3
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
14
59
2.40
2.30
1.4
1.4
g/l
6.1
6.1
—
9
40
(3024139) IgG subclass 3 [Mass/volume] in Serum
14
59
2.40
2.30
1.4
1.4
g/l
0.4
0.3
—
9
40
(4062490)
14
59
2.40
2.30
1.4
1.4
—
—
—
0
0
(3028192) IgG subclass 2 [Mass/volume] in Serum
14
59
2.40
2.30
1.4
1.4
g/l
3.5
2.8
—
9
38
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
83
1111
0.71
2.25
1.3
1.3
iu/ml
9.8
24.7
6.26
18
374
(1761482) Bacteria [#/volume] in Urine by Culture
17
80
2.16
2.20
8.9
2.8
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
17
82
2.10
2.08
1.2
1.2
—
—
—
0
0
(3011648) Oxygen content in Venous blood
9
31
2.93
2.08
1.7
2.0
%
13.3
11.4
—
9
31
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
46
304
1.55
2.04
1.1
1.3
miu/ml
264.7
234.3
0.17
17
159
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
6
15
4.03
2.04
1.0
1.1
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
6
15
4.03
2.04
1.0
1.1
%
79.7
98.9
—
6
15
(1002224) Polysomnography panel
17
324
0.51
2.04
1.1
1.1
—
—
—
0
0
(40768441) Liver Pathology biopsy report
10
38
2.66
2.01
1.1
1.5
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
36
225
1.64
2.01
2.8
2.5
e9/l
64.3
77.8
1.56
25
157
(3005033) Fetal Nuchal fold Thickness US
14
282
0.49
1.98
1.3
1.4
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
75
551
1.41
1.98
1.9
1.5
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
15
292
0.50
1.93
1.3
1.5
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
51
0.00
1.89
0.0
1.1
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
21
365
0.56
1.88
1.3
1.5
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
478
5051
0.79
1.86
3.4
3.5
mmol/l
5.6
5.7
0.66
437
4783
(3051651) Icteric interference index of Serum or Plasma
6
17
3.55
1.84
1.0
4.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
22
375
0.57
1.84
1.3
1.5
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
5
12
4.19
1.82
4.4
1.8
umol/l
14.4
16.9
—
5
12
(3042936) Bacteria identified in Isolate by Culture
78
587
1.37
1.81
1.8
2.0
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
15
285
0.51
1.81
1.3
1.4
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
21
116
1.84
1.80
1.6
1.8
g/l
3.4
3.9
1.48
15
91
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
21
116
1.84
1.80
1.6
1.8
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
21
116
1.84
1.80
1.6
1.8
g/l
6.6
7.3
1.06
15
97
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
18
323
0.54
1.80
1.3
1.7
mg/l
5.1
2.8
—
9
216
(3024354) Oxygen [Partial pressure] in Venous blood
37
241
1.57
1.77
9.8
2.5
kpa
4.7
4.9
0.18
37
236
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
175
1476
1.26
1.77
2.3
2.5
u/l
51.3
55.2
1.21
161
1389
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
24
2.94
1.72
1.1
1.2
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
40
268
1.53
1.70
2.1
1.7
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
20
111
1.83
1.70
1.5
1.8
g/l
2.9
3.0
0.23
15
92
(3003338) MCHC [Mass/volume]
476
5019
0.80
1.70
26.4
12.6
g/l
332.8
332.7
0.13
476
4987
(3000991) Gas panel - Venous blood
40
270
1.51
1.65
12.5
8.1
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
166
1404
1.25
1.63
1.3
1.3
u/ml
0.9
1.8
0.98
39
407
(3004588) Protein electrophoresis panel - Serum or Plasma
31
198
1.59
1.63
1.5
2.1
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
78
598
1.35
1.62
1.6
1.6
nmol/l
1096.9
1183.5
0.42
62
483
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
5
14
3.59
1.62
2.8
1.9
ug/l
47.5
52.7
—
5
14
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
64
846
0.73
1.62
1.8
1.8
%
1.5
1.3
1.48
58
778
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
437
4641
0.81
1.61
3.6
3.8
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
13
63
2.09
1.60
1.2
1.0
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
26
160
1.65
1.58
1.8
1.9
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
78
604
1.33
1.53
2.4
2.2
g/l
2.6
2.4
1.10
73
559
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
27
170
1.61
1.51
7.7
12.9
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
107
867
1.28
1.51
1.4
1.6
pmol/l
479.7
26209082.1
1.05
97
786
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
24
147
1.66
1.49
1.9
1.7
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
58
432
1.38
1.46
2.6
2.3
u/l
24.8
33.3
2.07
43
363
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
9
38
2.39
1.46
1.0
1.1
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
5
16
3.14
1.44
1.2
1.1
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
9
39
2.33
1.43
1.1
2.9
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
76
593
1.32
1.42
1.4
1.4
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
412
3847
1.20
1.41
2.9
3.7
mm/h
9.3
9.2
0.06
381
3641
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
9
40
2.27
1.40
1.0
1.2
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
84
667
1.30
1.39
2.5
2.2
umol/l
15.6
14.8
0.35
77
610
(3026493) Urate [Moles/volume] in Serum or Plasma
95
1163
0.78
1.39
1.8
2.2
umol/l
4284.8
4682.7
0.03
89
1057
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
26
167
1.58
1.36
1.5
1.4
u/l
28.7
23.0
0.37
18
139
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
60
777
0.75
1.34
2.0
2.0
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
13
68
1.93
1.34
23.4
3.2
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
16
90
1.80
1.34
1.3
4.0
—
329.0
—
0
10
(3051387) C reactive protein [Mass/volume] in Capillary blood
15
83
1.83
1.32
4.7
3.5
mg/l
28.9
25.3
—
9
55
(40768443) Skin Pathology biopsy report
28
185
1.54
1.31
1.3
1.1
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
41
294
1.42
1.30
11.2
6.8
mmol/l
1.2
1.3
0.07
41
285
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
13
69
1.90
1.29
1.3
2.7
—
983.0
—
0
6
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
20
122
1.66
1.28
1.0
1.2
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
5
18
2.79
1.28
2.4
2.7
umol/l
7.9
18.1
—
5
18
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
12
62
1.95
1.28
1.4
1.8
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
17
99
1.74
1.28
1.9
1.6
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
105
871
1.25
1.23
1.4
1.4
titre
228.1
519.8
5.62
27
181
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
23
344
0.66
1.18
1.3
1.4
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
46
343
1.37
1.18
12.3
10.7
inr
1.0
1.2
—
10
58
(3013139) Helicobacter pylori Ag [Presence] in Stool
26
379
0.67
1.18
1.2
1.2
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
11
57
1.95
1.17
1.2
1.4
mmol/l
9.7
11.4
—
5
9
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
23
343
0.66
1.17
1.3
1.4
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
10
50
2.02
1.17
1.2
1.1
mg/l
259.6
290.6
—
10
45
(3045414) Leukocytes [Presence] in Urine
32
224
1.45
1.16
2.1
1.6
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
47
353
1.36
1.16
6.6
9.5
mmol/l
0.6
1.0
0.18
33
273
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
52
397
1.34
1.16
2.4
2.6
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
5
20
2.51
1.15
1.0
1.5
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
23
341
0.66
1.14
1.3
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
23
341
0.66
1.14
1.3
1.4
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
0
36
0.00
1.14
0.0
1.7
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
28
193
1.47
1.11
1.7
2.4
ng/l
67.8
74.6
0.14
21
170
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
7
31
2.27
1.10
1.4
1.1
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
594
5805
1.34
1.08
13.6
9.6
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
87
718
1.25
1.08
2.2
2.8
ng/l
572.4
550.0
0.03
72
582
(3045424) Erythrocytes [Presence] in Urine
15
89
1.70
1.08
2.1
1.4
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
7
32
2.20
1.08
7.3
10.1
mmol/l
6.2
6.7
—
7
27
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
13
74
1.77
1.07
1.1
1.2
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
13
74
1.77
1.07
1.1
1.2
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
531
5130
1.21
1.03
6.2
4.8
mu/l
1.6
1.9
0.88
507
4906
(3008898) HLA-B27 [Presence]
21
309
0.67
1.02
1.0
1.1
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
10
53
1.90
1.01
2.3
4.3
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
15
91
1.66
1.01
1.6
2.3
ug/l
377.3
267.0
0.25
15
79
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
7
35
2.01
1.00
2.4
1.7
u/field
2.6
0.9
—
7
27
(3033705) Calcium.ionized [Moles/volume] in Venous blood
7
36
1.95
0.97
1.6
2.3
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
12
198
0.60
0.97
1.2
1.4
pmol/l
82.3
117.1
0.25
12
192
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
0
32
0.00
0.95
0.0
9.6
—
44.8
—
0
13
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
66
537
1.26
0.95
2.6
2.3
%
26.0
24.7
0.24
52
456
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
17
109
1.57
0.94
1.6
1.3
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
17
109
1.57
0.94
1.0
1.3
u/ml
1.3
4.3
—
6
35
(3041354) Potassium [Moles/volume] in Venous blood
7
37
1.90
0.94
1.6
2.4
mmol/l
4.2
4.0
—
7
37
(3035285) Chloride [Moles/volume] in Venous blood
7
37
1.90
0.94
1.6
2.4
mmol/l
106.0
106.0
—
7
37
(3009542) Hematocrit [Volume Fraction] of Blood
518
5340
0.84
0.94
21.2
10.9
%
39.5
40.2
1.17
385
4495
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
17
110
1.56
0.91
1.2
1.4
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
10
170
0.58
0.91
1.3
1.2
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
32
237
1.37
0.89
1.6
1.7
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
21
144
1.47
0.88
3.1
3.7
g/l
0.3
0.3
—
6
62
(4024509)
6
30
2.01
0.87
1.5
1.3
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
30
2.01
0.87
1.0
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
10
167
0.59
0.86
1.3
1.2
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
21
297
0.70
0.86
1.5
1.8
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
17
112
1.53
0.85
1.0
1.3
u/ml
3.0
6.3
—
5
43
(3049717) Cytology report of Urine Cyto stain
15
96
1.58
0.85
1.9
1.9
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
54
663
0.80
0.84
1.2
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
10
166
0.60
0.84
1.3
1.2
—
—
—
0
0
(3022145) Colonoscopy Study observation
45
564
0.78
0.84
1.2
1.3
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
129
1137
1.17
0.83
2.0
1.9
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
17
248
0.68
0.82
1.4
1.6
—
—
—
0
0
(3022313) Gas panel - Capillary blood
21
147
1.44
0.81
3.0
2.9
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
8
47
1.71
0.81
1.1
1.1
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
17
114
1.50
0.80
1.1
1.2
u/ml
263.3
215.6
0.26
12
69
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
107
1221
0.85
0.79
1.9
2.1
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
168
1516
1.15
0.79
1.6
1.5
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
0
24
0.00
0.79
0.0
2.1
—
632.5
—
0
16
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
6
33
1.83
0.79
3.3
9.0
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
167
1507
1.15
0.79
2.1
1.9
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
7
122
0.57
0.78
1.1
1.2
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
26
0.00
0.78
0.0
1.0
—
40.6
—
0
26
(44786774) Adalimumab [Mass/volume] in Serum or Plasma
0
27
0.00
0.77
0.0
2.4
—
9.7
—
0
22
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
0
27
0.00
0.77
0.0
1.1
—
33.3
—
0
7
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
28
369
0.75
0.76
1.7
2.1
ml/min/173m2
87.1
78.9
0.95
11
143
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
26
195
1.35
0.70
1.2
1.3
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
9
58
1.56
0.70
1.2
1.3
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
28
213
1.33
0.69
1.0
1.2
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
93
1060
0.86
0.69
5.5
3.8
mg/mmol
3.7
10.4
2.34
62
678
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
50
603
0.81
0.69
1.3
1.5
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
16
110
1.47
0.69
1.0
1.1
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
10
61
1.65
0.69
1.0
1.5
—
—
—
0
0
(3002256) Pathology report gross observation
75
645
1.18
0.67
1.3
1.2
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
5
28
1.79
0.66
1.2
1.8
nmol/l
122.2
154.4
—
5
28
(4198724)
5
28
1.79
0.66
1.0
1.9
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
19
137
1.40
0.65
2.9
3.0
mmol/l
24.9
24.6
0.24
19
131
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
8
49
1.64
0.62
1.0
1.0
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
8
49
1.64
0.62
4.0
2.3
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
10
63
1.60
0.62
1.0
1.1
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
5
30
1.67
0.61
1.6
2.9
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
8
50
1.61
0.61
1.1
1.7
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
9
137
0.65
0.61
1.2
1.1
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
57
483
1.20
0.60
5.6
5.0
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
71
614
1.18
0.60
1.2
1.3
iu/l
35.0
27.4
0.90
63
523
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
(3019060) Gas panel - Arterial blood
24
183
1.32
0.60
6.3
8.3
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
0
21
0.00
0.60
0.0
1.1
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
124
1119
1.13
0.60
2.2
2.0
mg/l
2.9
2.7
0.35
106
975
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
22
0.00
0.59
0.0
1.5
—
8.3
—
0
22
(3041806) Other cells [#/volume] in Blood by Manual count
0
22
0.00
0.59
0.0
1.6
—
—
—
0
0
(4268621)
11
72
1.54
0.59
1.6
2.4
—
—
—
0
0
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
0
23
0.00
0.58
0.0
2.8
—
167.5
—
0
5
(3016750) Collection duration of Urine
0
23
0.00
0.58
0.0
1.9
—
483.6
—
0
16
(3006442) Creatine [Moles/volume] in Serum or Plasma
8
54
1.49
0.57
1.1
1.4
—
64.4
—
0
5
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
12
172
0.69
0.57
2.4
1.6
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
11
158
0.69
0.53
1.1
1.1
u/ml
0.5
1.7
—
5
36
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
6
39
1.54
0.53
1.0
1.3
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
58
500
1.18
0.53
3.4
3.4
%
29.8
31.6
0.93
50
382
(3028707) Methadone [Presence] in Urine by Screen method
20
152
1.33
0.52
3.1
1.9
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
72
632
1.16
0.52
3.0
3.0
mmol/l
0.8
0.8
0.01
67
605
(4035726)
30
368
0.81
0.51
1.2
1.3
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
237
2236
1.10
0.51
1.9
1.9
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
7
107
0.65
0.49
1.1
1.3
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
112
1226
0.90
0.48
4.7
3.0
mmol/l
8.1
7.9
0.22
98
1086
(4306422)
14
102
1.38
0.47
1.1
1.2
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
21
164
1.29
0.47
6.1
9.7
mmol/l
24.4
24.0
0.20
21
157
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
49
567
0.85
0.47
1.4
1.8
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
15
111
1.36
0.47
1.9
1.6
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
91
1006
0.89
0.46
1.4
1.7
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
33
395
0.83
0.46
1.6
1.5
—
—
—
0
0
(3044889) 12 lead EKG panel
351
3382
1.08
0.45
2.7
2.8
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
5
31
1.62
0.43
3.6
3.0
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
8
56
1.43
0.42
1.4
1.4
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
5
32
1.57
0.42
1.2
1.5
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
76
683
1.13
0.41
2.0
2.3
mmol/l
2.4
2.4
0.79
60
601
(3016879) Cocaine [Presence] in Urine
26
315
0.82
0.41
5.3
1.7
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
254
2423
1.08
0.41
3.7
3.8
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
5
33
1.52
0.41
1.2
1.5
u/l
7.2
6.9
—
5
28
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3033923) Metanephrine [Moles/time] in 24 hour Urine
0
17
0.00
0.40
0.0
1.1
—
0.6
—
0
12
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
0
17
0.00
0.40
0.0
1.0
—
220.7
—
0
12
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
0
17
0.00
0.40
0.0
1.0
—
593.8
—
0
12
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
0
17
0.00
0.40
0.0
1.0
—
33.9
—
0
11
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
161
1509
1.09
0.40
2.7
2.6
ng/l
86.0
27.9
0.50
76
704
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
18
0.00
0.40
0.0
6.6
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
14
182
0.76
0.39
1.1
1.1
u/ml
0.6
2.1
—
5
70
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
0
19
0.00
0.39
0.0
1.0
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
16
124
1.30
0.39
1.4
1.0
u/ml
0.9
2.5
—
6
65
(3012516) Albumin [Mass/volume] in Urine
94
1023
0.90
0.37
4.8
3.2
mg/l
1363.1
437.5
0.47
64
659
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
14
107
1.32
0.37
1.2
1.4
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
39
337
1.17
0.37
1.2
1.2
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
28
332
0.84
0.37
5.0
1.7
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
15
116
1.30
0.37
1.1
1.1
—
—
—
0
0
(4010399)
37
319
1.17
0.36
1.4
1.4
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
67
741
0.89
0.36
1.6
1.9
—
—
—
0
0
(4094501)
9
122
0.73
0.35
1.1
1.1
—
—
—
0
0
(3020891) Body temperature
16
126
1.28
0.35
2.3
4.6
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
13
167
0.77
0.34
1.0
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
13
167
0.77
0.34
1.0
1.1
—
—
—
0
0
(4034850)
20
163
1.23
0.34
7.5
7.7
—
—
—
0
0
(3019225) pH of Specimen
43
378
1.15
0.34
2.7
3.4
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
45
1.34
0.34
1.2
1.4
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
156
1473
1.08
0.33
2.1
3.1
mmol/l
2.3
2.3
0.85
132
1352
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
6
47
1.28
0.32
2.2
3.2
u/ml
41.8
64.1
—
6
47
(3025018) Bordetella pertussis Ab [Titer] in Serum
6
47
1.28
0.32
1.3
1.2
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
16
128
1.26
0.32
1.3
1.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
29
337
0.85
0.32
4.9
1.7
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
42
371
1.14
0.31
1.1
1.1
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
29
336
0.86
0.31
4.9
1.6
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
26
221
1.18
0.31
2.7
2.8
kpa
5.3
5.1
0.68
26
208
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
456
4472
1.07
0.31
5.4
4.2
pmol/l
14.4
14.3
0.66
428
4247
(3000764) Benzodiazepines [Presence] in Urine
29
335
0.86
0.30
4.9
1.6
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
17
206
0.82
0.29
1.5
2.0
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
7
57
1.23
0.29
1.6
1.1
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
131
1237
1.07
0.28
1.8
1.7
mg/l
0.9
0.7
0.29
84
920
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
12
151
0.79
0.28
1.6
2.5
mg/l
9.0
10.0
0.20
12
140
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
10
76
1.32
0.28
1.7
1.2
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
54
491
1.11
0.27
1.3
1.2
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
5
71
0.70
0.26
1.4
1.3
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
20
235
0.85
0.26
6.2
2.1
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
9
73
1.24
0.25
1.1
1.4
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
6
81
0.74
0.24
2.7
2.7
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
104
1098
0.94
0.22
1.8
2.0
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
5
42
1.19
0.21
1.0
1.1
—
0.3
—
0
6
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.0
—
7.1
—
0
11
(3017569) Oxygen content in Arterial blood
0
11
0.00
0.21
0.0
9.7
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
8
101
0.79
0.21
1.1
1.5
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
12
0.00
0.21
0.0
1.3
—
1.8
—
0
12
(3006576) Bicarbonate [Moles/volume] in Blood
0
12
0.00
0.21
0.0
8.3
—
26.4
—
0
12
(44806071)
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
0
12
0.00
0.21
0.0
5.1
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
12
0.00
0.21
0.0
1.8
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
19
219
0.86
0.20
1.5
1.8
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
14
166
0.84
0.20
1.0
1.1
u/ml
2.5
4.2
—
7
80
(1001926) Buprenorphine [Presence] in Urine by Screen method
23
261
0.88
0.20
6.0
1.6
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
6
48
1.25
0.20
1.0
1.4
mmol/l
53.3
67.9
—
6
43
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
0
14
0.00
0.20
0.0
2.0
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
0
14
0.00
0.20
0.0
2.0
—
—
—
0
0
(3011897) Casein IgE Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
0
14
0.00
0.20
0.0
2.0
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
273
2796
0.96
0.19
3.0
2.8
ug/l
85.0
77.9
0.20
258
2667
(3039162) Centromere protein B Ab [Units/volume] in Serum
10
81
1.24
0.19
1.0
1.4
—
25.3
—
0
6
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
6
53
1.13
0.18
1.2
1.4
—
—
—
0
0
(1616796) Gas panel - Central venous blood
6
77
0.78
0.15
1.3
1.7
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
9
82
1.10
0.15
4.8
1.8
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
165
1698
0.96
0.14
1.5
1.6
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
18
202
0.89
0.14
1.2
1.5
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
8
97
0.82
0.14
1.0
1.3
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
28
304
0.92
0.13
7.7
3.1
mmol/l
1.2
1.2
0.38
23
265
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
28
304
0.92
0.13
2.0
4.2
ug/l
2.5
7.3
2.11
19
229
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
20
181
1.11
0.12
1.1
1.1
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
13
114
1.14
0.12
1.1
1.2
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
36
337
1.07
0.11
1.4
1.6
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
11
95
1.16
0.11
2.3
4.0
mmol/l
3.7
3.8
0.12
11
87
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
127
1303
0.97
0.10
1.6
1.7
mmol/l
1.5
1.4
0.64
105
1149
(3016244) Insulin [Units/volume] in Serum or Plasma
5
48
1.04
0.09
1.4
4.2
mu/l
16.2
26.6
—
5
48
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
24
223
1.08
0.09
1.3
1.5
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
6
55
1.09
0.09
1.2
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
6
55
1.09
0.09
1.2
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
6
55
1.09
0.09
1.2
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
6
56
1.07
0.08
1.2
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
6
56
1.07
0.08
1.2
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
6
56
1.07
0.08
1.2
1.2
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
5
60
0.83
0.08
1.2
1.6
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
7
64
1.09
0.08
1.1
1.4
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
7
81
0.86
0.07
1.0
1.2
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
7
80
0.87
0.07
1.0
1.3
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
7
85
0.82
0.07
3.0
2.4
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
152
1495
1.02
0.06
1.6
1.6
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
30
315
0.95
0.06
1.7
2.3
ug/l
0.6
0.7
0.16
16
150
(3023430) Cat dander IgE Ab [Units/volume] in Serum
12
130
0.92
0.04
1.1
1.1
u/ml
3.3
5.4
—
6
44
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
44
427
1.03
0.04
2.5
3.3
%
22.4
21.3
0.12
17
141
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
27
281
0.96
0.04
1.4
1.5
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
12
111
1.08
0.04
1.9
1.8
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
17
164
1.04
0.00
1.1
1.2
—
2.7
—
0
20
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
35
356
0.98
0.00
1.5
1.5
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
11
114
0.96
0.00
1.0
1.1
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
14
144
0.97
0.00
1.6
1.3
ug/g
281.1
323.9
—
8
80
(44816559) Phosphatidylethanol [Mass/volume] in Blood
15
146
1.03
0.00
1.1
1.3
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
19
186
1.02
0.00
2.6
2.2
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
16
157
1.02
0.00
1.8
1.7
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
55
546
1.01
0.00
1.3
1.2
iu/ml
230.4
164.3
0.43
20
232
(40768793) Breast Pathology biopsy report
16
162
0.99
0.00
1.2
1.2
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
79
793
1.00
0.00
1.9
2.5
ug/g
193.8
95.7
0.44
50
640
(3024891) Influenza virus A+B Ag [Presence] in Specimen
20
201
0.99
0.00
1.1
1.1
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
6
62
0.97
0.00
1.5
1.3
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
6
62
0.97
0.00
1.5
1.3
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
7
0.00
0.00
0.0
3.0
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
6
64
0.94
0.00
1.2
1.2
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
6
64
0.94
0.00
1.5
1.3
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
6
64
0.94
0.00
1.5
1.3
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
19
190
1.00
0.00
1.0
1.4
—
9.2
—
0
6
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.7
—
36.0
—
0
6
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
6.5
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
9
99
0.91
0.00
1.1
1.5
—
—
—
0
0
(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3051339) Copper [Moles/volume] in Blood
0
9
0.00
0.00
0.0
1.1
—
16.4
—
0
9
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
8
0.00
0.00
0.0
7.0
—
—
—
0
0
(4281824)
5
58
0.86
0.00
1.0
1.1
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
6
63
0.95
0.00
1.5
1.3
—
—
—
0
0
(4015189)
0
6
0.00
0.00
0.0
3.7
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
5
56
0.89
0.00
2.4
1.8
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
6
61
0.98
0.00
1.5
1.3
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032700) Glomerular basement membrane Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005082) Progesterone [Moles/volume] in Serum or Plasma
6
60
1.00
0.00
1.2
1.3
nmol/l
23.1
32.1
—
6
47
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
6
61
0.98
0.00
1.7
1.4
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
0
8
0.00
0.00
0.0
9.3
—
—
—
0
0
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
6
0.00
0.00
0.0
11.3
—
—
—
0
0
(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis
0
5
0.00
0.00
0.0
3.6
—
22.2
—
0
5
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
8
0.00
0.00
0.0
9.4
—
—
—
0
0
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
0
6
0.00
0.00
0.0
1.5
—
2.7
—
0
6
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
7
70
1.00
0.00
1.3
1.3
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3013466) aPTT in Blood by Coagulation assay
0
6
0.00
0.00
0.0
1.0
—
36.0
—
0
6
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020356) Listeria sp identified in Specimen by Organism specific culture
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013945) Hepatitis B virus e Ab [Presence] in Serum
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
3.4
—
—
—
0
0
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
7.0
—
0.3
—
0
6
(3032352) Blasts [#/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
2.8
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
8
0.00
0.00
0.0
3.5
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
67.0
—
0
6
(3034092) Cytoplasmic Ig cells/100 cells in Blood
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3011048) Pyruvate [Moles/volume] in Blood
0
6
0.00
0.00
0.0
1.2
—
91.2
—
0
6
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
0
9
0.00
0.00
0.0
1.8
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: MSMED_GLATIRAMERACETATE – Use of glatiramer acetate

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).